López Santamaria M, Vazquez J, Gamez M, Murcia J, Bueno J, Martinez L, Paz Cruz J A, Reinoso F, Bourgeois P, Diaz M C, Hierro L, Camarena C, de la Vega A, Frauca E, Jara P, Tovar J A
Department of Pediatric Surgery, Hospital Infantil La Paz, Madrid, Spain.
J Pediatr Surg. 1996 Apr;31(4):600-3. doi: 10.1016/s0022-3468(96)90506-0.
The authors compared the results of 48 orthotopic liver transplantations (OLT) in which revascularization was achieved with a conduit interposed between the receptor aorta and the graft (vascular graft [VG] group) with those obtained for 56 OLT performed during the same period (1991 to 1994) in which end-to-end anastomosis (EEA) of the hepatic arteries or celiac trunk was used (EEA group). In the VG group, the interposed conduits were the cadaveric iliac artery (37) the living-donor saphenous vein (3), or nonthrombosed conduits from previous transplants (8) (7 iliac arteries, 1 saphenous vein). There were significant differences between the two groups with respect to recipient age, recipient weight, the retransplant:first transplant ratio, the number of emergency transplantations, the use of reduced-size grafts, and intraoperative transfusion requirements. Twenty-nine grafts in the VG group (60.4%) and 43 in the EEA group (76.7%) currently are functioning. The actuarial 3-year graft survival rates are 60% and 71.5% for the VG and EEA groups (P < .05), respectively. The rate of arterial thrombosis did not differ between the two groups. The authors conclude that, although EEA of the hepatic artery is still the preferred revascularization technique for OLT, revascularization of the liver graft by conduit interposition is safe when EEA is not possible. Reutilization of the interposed conduit during retransplantation proved to be safe in the absence of hepatic artery thrombosis.
作者比较了48例原位肝移植(OLT)的结果,这些移植中通过在受体主动脉和移植物之间插入管道实现血管重建(血管移植物[VG]组),并与同期(1991年至1994年)进行的56例OLT的结果进行了比较,后者采用肝动脉或腹腔干的端端吻合术(EEA组)。在VG组中,插入的管道为尸体髂动脉(37例)、活体供者大隐静脉(3例)或来自先前移植的未形成血栓的管道(8例)(7例髂动脉,1例大隐静脉)。两组在受体年龄、受体体重、再次移植与首次移植比例、急诊移植数量、使用减体积移植物以及术中输血需求方面存在显著差异。VG组目前有29例移植物(60.4%)功能良好,EEA组有43例(76.7%)。VG组和EEA组的3年移植物精算生存率分别为60%和71.5%(P<0.05)。两组的动脉血栓形成率无差异。作者得出结论,虽然肝动脉端端吻合术仍是OLT首选的血管重建技术,但在无法进行端端吻合时,通过插入管道对肝移植物进行血管重建是安全的。在再次移植过程中,在无肝动脉血栓形成的情况下,证明再次使用插入的管道是安全的。